2015-2019 Alternative Scenarios of the Future In Vitro Diagnostics Industry: Business-as-Usual, Economic Austerity, Technological Breakthroughs
This new report is designed to help executives develop effective contingency plans that best accommodate uncertainties ahead. The study objectives include:
Contains 255 pages and 32 tables
- To identify and evaluate emerging markets and technologies that may present unexpected threats or offer opportunities.
- To identify key strategic decisions that will have to be made in the future.
- To enhance corporate ability to develop realistic contingency plans.
- To prepare executives to accommodate radically different operating climates and reduce surprises.
- To challenge accepted perceptions of the future diagnostics market.
- How will the future reimbursement changes affect individual market segments?
- Will the industry consolidate, decentralize, or undergo a bimodal transformation?
- What will be the impact on purchasing influences, marketing strategies, joint ventures, mergers, licensing, import and export?
- How will the future technological advances affect the major market segment?
- Which companies will enter the market and which will not survive?
Contains 255 pages and 32 tables
I. INTRODUCTION
II. AIDS/HIV WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Background
B. Diagnostic Tests: HIV-1/2, HIV Ag, NAT, Western Blot
C. Vaccines and Drugs
D. Instrumentation Review and Market Needs
E. Emerging Diagnostic Technologies
III. FRANCE: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS' SALES AND MARKET SHARES
IV. GERMANY: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS' SALES AND MARKET SHARES
V. ITALY: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS' SALES AND MARKET SHARES
VI. JAPAN: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS' SALES AND MARKET SHARES
VII. SPAIN: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS' SALES AND MARKET SHARES
VIII. UK: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS' SALES AND MARKET SHARES
IX. USA: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS' SALES AND MARKET SHARES
X. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
XI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XII. COMPETITIVE ASSESSMENTS
Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix
DiaSorin
Eiken Chemical
Enzo Biochem
Fujirebio
Gen-Probe
Hologic
ID Biomedical
Innogenetics/Solvay
Ortho-Clinical Diagnostics/J&J
Kreatech
Life Technologies
Lonza
Nanogen/Elitech
Novartis
PerkinElmer
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wako
II. AIDS/HIV WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Background
B. Diagnostic Tests: HIV-1/2, HIV Ag, NAT, Western Blot
C. Vaccines and Drugs
D. Instrumentation Review and Market Needs
E. Emerging Diagnostic Technologies
III. FRANCE: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS' SALES AND MARKET SHARES
IV. GERMANY: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS' SALES AND MARKET SHARES
V. ITALY: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS' SALES AND MARKET SHARES
VI. JAPAN: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS' SALES AND MARKET SHARES
VII. SPAIN: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS' SALES AND MARKET SHARES
VIII. UK: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS' SALES AND MARKET SHARES
IX. USA: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS' SALES AND MARKET SHARES
X. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
XI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XII. COMPETITIVE ASSESSMENTS
Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix
DiaSorin
Eiken Chemical
Enzo Biochem
Fujirebio
Gen-Probe
Hologic
ID Biomedical
Innogenetics/Solvay
Ortho-Clinical Diagnostics/J&J
Kreatech
Life Technologies
Lonza
Nanogen/Elitech
Novartis
PerkinElmer
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wako
LIST OF TABLES
Major Companies Developing or Marketing AIDS Tests
France: HIV or HIV-1/2 Test Volume and Sales Forecasts By Market Segment
France: HIV Ag Test Volume and Sales Forecasts By Market Segment
France: HIV NAT Blood Screening Test Volume and Diagnostics Sales
France: Western Blot/Other Confirmatory Tests Volume and Sales Forecasts by Market Segment
France: AIDS Diagnostics Market by Major Supplier
France: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers
Germany: HIV or HIV-1/2 Test Volume and Sales Forecasts By Market Segment
Germany: HIV Ag Test Volume and Sales Forecasts By Market Segment
Germany: HIV NAT Blood Screening Test Volume and Diagnostics Sales
Germany: Western Blot/Other Confirmatory Tests Volume and Sales Forecasts by Market Segment
Germany: AIDS Diagnostics Market by Major Supplier
Germany: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers
Italy: HIV or HIV-1/2 Test Volume and Sales Forecasts By Market Segment
Italy: HIV Ag Test Volume and Sales Forecasts By Market Segment
Italy: HIV NAT Blood Screening Test Volume and Diagnostics Sales
Italy: Western Blot/Other Confirmatory Tests Volume and Sales Forecasts by Market Segment
Italy: AIDS Diagnostics Market by Major Supplier
Italy: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers
Japan: HIV or HIV-1/2 Test Volume and Sales Forecasts By Market Segment
Japan HIV Ag Test Volume and Sales Forecasts By Market Segment
Japan: HIV NAT Blood Screening Test Volume and Diagnostics Sales
Japan: Western Blot/Other Confirmatory Tests Volume and Sales Forecasts by Market Segment
Japan: AIDS Diagnostics Market by Major Supplier
Japan: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers
Spain: HIV or HIV-1/2 Test Volume and Sales Forecasts By Market Segment
Spain: HIV Ag Test Volume and Sales Forecasts By Market Segment
Spain: HIV NAT Blood Screening Test Volume and Diagnostics Sales
Spain: Western Blot/Other Confirmatory Tests Volume and Sales Forecasts by Market Segment
Spain: AIDS Diagnostics Market by Major Supplier
Spain: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers
UK: HIV or HIV-1/2 Test Volume and Sales Forecasts By Market Segment
UK: HIV Ag Test Volume and Sales Forecasts By Market Segment
UK: HIV NAT Blood Screening Test Volume and Diagnostics Sales
UK: Western Blot/Other Confirmatory Tests Volume and Sales Forecasts by Market Segment
UK: AIDS Diagnostics Market by Major Supplier
UK: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers
USA: HIV or HIV-1/2 Test Volume and Sales Forecasts By Market Segment
USA: HIV Ag Test Volume and Sales Forecasts By Market Segment
USA: HIV NAT Blood Screening Test Volume and Diagnostics Sales
USA: Western Blot/Other Confirmatory Tests Volume and Sales Forecasts by Market Segment
USA: AIDS Diagnostics Market by Major Supplier
USA: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers
Major Companies Developing or Marketing AIDS Tests
France: HIV or HIV-1/2 Test Volume and Sales Forecasts By Market Segment
France: HIV Ag Test Volume and Sales Forecasts By Market Segment
France: HIV NAT Blood Screening Test Volume and Diagnostics Sales
France: Western Blot/Other Confirmatory Tests Volume and Sales Forecasts by Market Segment
France: AIDS Diagnostics Market by Major Supplier
France: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers
Germany: HIV or HIV-1/2 Test Volume and Sales Forecasts By Market Segment
Germany: HIV Ag Test Volume and Sales Forecasts By Market Segment
Germany: HIV NAT Blood Screening Test Volume and Diagnostics Sales
Germany: Western Blot/Other Confirmatory Tests Volume and Sales Forecasts by Market Segment
Germany: AIDS Diagnostics Market by Major Supplier
Germany: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers
Italy: HIV or HIV-1/2 Test Volume and Sales Forecasts By Market Segment
Italy: HIV Ag Test Volume and Sales Forecasts By Market Segment
Italy: HIV NAT Blood Screening Test Volume and Diagnostics Sales
Italy: Western Blot/Other Confirmatory Tests Volume and Sales Forecasts by Market Segment
Italy: AIDS Diagnostics Market by Major Supplier
Italy: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers
Japan: HIV or HIV-1/2 Test Volume and Sales Forecasts By Market Segment
Japan HIV Ag Test Volume and Sales Forecasts By Market Segment
Japan: HIV NAT Blood Screening Test Volume and Diagnostics Sales
Japan: Western Blot/Other Confirmatory Tests Volume and Sales Forecasts by Market Segment
Japan: AIDS Diagnostics Market by Major Supplier
Japan: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers
Spain: HIV or HIV-1/2 Test Volume and Sales Forecasts By Market Segment
Spain: HIV Ag Test Volume and Sales Forecasts By Market Segment
Spain: HIV NAT Blood Screening Test Volume and Diagnostics Sales
Spain: Western Blot/Other Confirmatory Tests Volume and Sales Forecasts by Market Segment
Spain: AIDS Diagnostics Market by Major Supplier
Spain: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers
UK: HIV or HIV-1/2 Test Volume and Sales Forecasts By Market Segment
UK: HIV Ag Test Volume and Sales Forecasts By Market Segment
UK: HIV NAT Blood Screening Test Volume and Diagnostics Sales
UK: Western Blot/Other Confirmatory Tests Volume and Sales Forecasts by Market Segment
UK: AIDS Diagnostics Market by Major Supplier
UK: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers
USA: HIV or HIV-1/2 Test Volume and Sales Forecasts By Market Segment
USA: HIV Ag Test Volume and Sales Forecasts By Market Segment
USA: HIV NAT Blood Screening Test Volume and Diagnostics Sales
USA: Western Blot/Other Confirmatory Tests Volume and Sales Forecasts by Market Segment
USA: AIDS Diagnostics Market by Major Supplier
USA: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers